Note AcademyNote Academy

Biology · Oct / Nov 2020 · Paper 11 · Question 7

YBI11

As printed in the paper

The question as text

7 Warfarin is used in the treatment of cardiovascular disease. Warfarin inhibits the synthesis of prothrombin.

Read automatically from the paper; the printed page above is exact.

Show the answer and mark scheme
  • 7(a)[3]

    A description that includes the following point:

    ACCEPT precursor of clotting process /

    to be present in the blood (all the time) (1)

    inactive form of thrombin / inactive

    enzyme / inactive plasma protein

    and any TWO of the following:

    needed to make thrombin (when blood needs to clot) (1)

    which is an {enzyme / catalyst} (1)

    so that fibrinogen can be converted into fibrin (1)

    NB thrombin catalyses fibrinogen into

    fibrin = 2 marks

  • 7(b)[1]

    The only correct answer is A

    A anticoagulant

    B is incorrect because antihypertensives treat high blood pressure

    C is incorrect because platelet inhibitors inhibit platelets, which are involved in the cascade before prothrombin and

    prothrombin is made by the liver

    D is incorrect because statins treat high blood cholesterol levels

  • 7(c)(i)[2]

    An answer that includes the following points:

    warfarin and vitamin K have a similar structure (1)

    ACCEPT both have rings / double bond

    oxygen

    therefore warfarin {binds / blocks} to the {vitamin K epoxide

    ACCEPT warfarin is a {competitive /

    reductase / VKOR} (1)

    activesite directed } inhibitor /

    description

    DO NOT ACCEPT noncompetitive

    inhibitor / description of one

    binds to vitamin K

    (as a result of warfarin binding to enzyme) {less / no} vitamin K

    reduced (1)

  • 7(c)(ii)[2]

    An answer that includes the following points:

    increase in vitamin K would compete with warfarin for the active

    ACCEPT a description e.g. more

    site (of vitamin K epoxide reductase / VKOR) (1)

    enzyme substrate complexes

    therefore {some / more} vitamin K will be reduced (if vitamin K

    binds to enzyme) (1)

  • 7(d)[4]

    An explanation that includes the following points:

    large groups of people (1)

    ACCEPT 20 +

    IGNORE reference to control groups

    (sample size is large) for reproducibility (1)

    ACCEPT repeatable / reliable

    IGNORE accurate / precise / valid

    people in both groups consume the same {mass / volume /

    IGNORE amount

    concentration} of vitamin K (1)

    people in both groups consume the same concentration of

    ACCEPT other appropriate named

    drugs (1)

    control variable e.g. sex, age, diet,

    level of activity, alcohol intake

    IGNORE same number of people in

    each group / amount

    (variables controlled) for validity (1)

    IGNORE accurate / precise

    /reproducible / repeatable / reliable

Make a free account to save your answers and see your weak topics and ask the AI why a wrong answer is wrong.